journal article·2025-03Open access

Extracellular matrix ligands modulate the endothelial progenitor cell secretome for enhanced angiogenesis

Vanessa F.C. Dartora, Randy Carney, Aijun Wang, Peng Qiu, Alyssa Panitch

Acta Biomaterialia· Volume 195

Abstract

Wound healing is a complex physiological process fundamentally dependent on angiogenesis for effective tissue repair. Endothelial progenitor cells (EPCs) have shown significant potential in promoting angiogenesis, primarily through their secretome, rich in proteins and extracellular vesicles (EVs) essential for cell signaling and tissue regeneration. This study investigates the effect of a collagen-bound proteoglycan mimetic (LXW7-DS-SILY or LDS), that binds to the αvβ3 integrin receptor, on the EPC secretome, with a dual focus on the proteomic content and the functional properties of EVs. Utilizing high-resolution two-dimensional liquid chromatography-tandem mass spectrometry (LC-MS/MS) alongside bioinformatic analysis, we identified significant alterations in protein expression profiles, particularly in angiogenesis and wound healing pathways. The functional impact of these changes was validated through biological assays, where the whole secretome and the EV fraction from EPCs seeded on collagen-bound LDS markedly enhanced vascular network formation, driven by the increase of growth factors and angiogenic regulators such as FGFR1, NRP1, and ANGPT2 within the EV fraction. Gene Ontology (GO) enrichment analysis further highlighted the enrichment of proteins within the EVs driving biological processes, including 'response to wounding' and 'positive regulation of cell motility'. These results underscore that LDS modulates the EPC secretome and significantly enhances its angiogenic potential, offering a promising therapeutic strategy for non-healing and ischemic wounds and suggesting that biomaterials can be modified to control the EV secretome to enhance tissue repair. Functional assays validating the omics data highlight the robustness of LDS as a targeted therapeutic for enhancing angiogenesis and tissue repair in clinical settings. Moreover, the pivotal role of EVs in mediating pro-angiogenic effects offers insights into developing biomaterial therapies that exploit key regulators within the EPC secretome for wound healing. STATEMENT OF SIGNIFICANCE: This manuscript explores how a proteoglycan mimetic that binds to both collagen and the αvβ3 integrin receptor affects the proteome component of the secretome from endothelial progenitor cells (EPCs). It presents functional biological data, analytical data, and proteomic analysis of the soluble and extracellular vesical (EV) components of the secratome. The proteomic data maps to the observed enhanced angiogenic potential of the EVs. These results suggest that by controlling the cellular environment and judicially engineering how cells interact with a biomaterial can influence the proteomic composition of EVs to enhance tissue regeneration. This is the foundation of future work aimed at engineering biomaterial cell systems to influence the proteomic component of EVs for therapeutic use.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · Cell Adhesion Molecules Research · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (94)

Show source-provided references
1. Wound healing - a literature review10.1590/abd1806-4841.20164741 ↗
2. Re-epithelialization: advancing epithelium frontier during wound healing10.1098/rsif.2013.1038 ↗
3. Angiogenesis in wound healing10.1046/j.1087-0024.2000.00014.x ↗
4. Angiogenesis and the skin10.1016/S0190-9622(87)70161-3 ↗
5. Therapeutic strategies for enhancing angiogenesis in wound healing10.1016/j.addr.2018.09.010 ↗
6. Stem cell therapy for dermal wound healing10.15283/ijsc.2010.3.1.29 ↗
7. Stem cells for cutaneous wound healing10.1155/2015/285869 ↗
8. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance10.1111/j.1582-4934.2004.tb00474.x ↗
9. Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactone/gelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis10.1186/s13287-018-0824-2 ↗
10. ECM-dependence of endothelial progenitor cell features10.1002/jcb.25492 ↗
11. Regenerative medicine and angiogenesis; challenges and opportunities10.34172/apb.2020.061 ↗
12. Cell secretome strategies for controlled drug delivery and wound-healing applications10.3390/polym14142929 ↗
13. X. Guo, C. Schaudinn, U. Blume-Peytavi, A. Vogt, F. Rancan, Effects of adipose-derived stem cells and their conditioned medium in a Human ex vivo wound model, Cells 11(7) (2022).10.3390/cells11071198 ↗
14. Stem cell secretome and its effect on cellular mechanisms relevant to wound healing10.1016/j.ymthe.2017.09.023 ↗
15. Secretome of mesenchymal stem cells grown in hypoxia accelerates wound healing and vessel formation in vitro10.23937/2469-570X/1410045 ↗
16. Secretome of adipose-derived stem cells cultured in platelet lysate improves migration and viability of keratinocytes10.3390/ijms24043522 ↗
17. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells10.3109/14653249.2010.512632 ↗
18. Delivery of stem cell secretome for therapeutic applications10.1021/acsabm.1c01312 ↗
19. Stem cell's secretome delivery systems10.34172/apb.2023.027 ↗
20. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time10.1016/j.jconrel.2016.01.009 ↗
21. Polymeric hydrogels as mesenchymal stem cell secretome delivery system in biomedical applications10.3390/polym14061218 ↗
22. Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration10.1002/adfm.201909125 ↗
23. Extracellular vesicle-based hydrogels for wound healing applications10.3390/ijms24044104 ↗
24. Design of a synthetic collagen-binding peptidoglycan that modulates collagen fibrillogenesis10.1021/bm8006852 ↗
25. The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans10.1016/j.biomaterials.2010.12.025 ↗
26. Proangiogenic collagen-binding glycan therapeutic promotes endothelial cell angiogenesis10.1021/acsbiomaterials.1c00336 ↗
27. Engineered multi-functional, pro-angiogenic collagen-based scaffolds loaded with endothelial cells promote large deep burn wound healing
28. Discovery and characterization of a potent and specific peptide ligand targeting endothelial progenitor cells and endothelial cells for tissue regeneration10.1021/acschembio.7b00118 ↗
29. Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing
30. Solid-phase peptide cyclization with two disulfide bridges10.1007/978-1-0716-1689-5_2 ↗
31. N-chlorosuccinimide, an efficient peptide disulfide bond-forming reagent in aqueous solution10.1039/c3ra43149e ↗
32. Molecular iodine-mediated cyclization of tethered heteroatom-containing alkenyl or alkynyl systems10.3390/molecules14124814 ↗
33. Convection and extracellular matrix binding control interstitial transport of extracellular vesicles10.1002/jev2.12323 ↗
34. Extracellular vesicles from highly metastatic osteosarcoma cells induce pro-tumorigenic macrophage phenotypes
35. Extracellular vesicles (EVs) are copurified with feline calicivirus, yet EV-enriched fractions remain infectious10.1128/spectrum.01211-22 ↗
36. K. Baijal, I. Abramchuk, C.M. Herrera, M. Stephen Trent, M. Lavallée-Adam, M. Downey, Proteomics analysis reveals a role for, bioRxiv (2023).
37. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets10.1038/s41467-019-09234-6 ↗
38. PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API10.1093/nar/gkaa1106 ↗
39. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)10.1093/nar/gkac194 ↗
40. ExoCarta: a web-based compendium of exosomal cargo10.1016/j.jmb.2015.09.019 ↗
41. Prediction of unconventional protein secretion by exosomes10.1186/s12859-021-04219-z ↗
42. Emerging roles of exosomes in T1DM10.3389/fimmu.2020.593348 ↗
43. Discovering biological progression underlying microarray samples10.1371/journal.pcbi.1001123 ↗
44. Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution10.1038/s41467-021-27263-y ↗
45. Stepwise differentiation and functional characterization of human induced pluripotent stem cell-derived choroidal endothelial cells10.1186/s13287-020-01903-4 ↗
46. Resident vascular endothelial progenitor definition and function: the age of reckoning10.1007/s10456-021-09817-2 ↗
47. Focus on mesenchymal stem cell-derived exosomes: opportunities and challenges in cell-free therapy10.1155/2017/6305295 ↗
48. Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process10.1038/s42003-023-04911-1 ↗
49. Heat shock protein A2 is a novel extracellular vesicle-associated protein10.1038/s41598-023-31962-5 ↗
50. Plasma-derived exosomal ALIX as a novel biomarker for diagnosis and classification of pancreatic cancer
51. Cells release subpopulations of exosomes with distinct molecular and biological properties10.1038/srep22519 ↗
52. Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy10.15171/apb.2016.041 ↗
53. Extracellular vesicle quantification and characterization: common methods and emerging approaches
54. Size and concentration analyses of extracellular vesicles by nanoparticle tracking analysis: a variation study10.1080/20013078.2017.1344087 ↗
55. Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility10.1080/20013078.2017.1396823 ↗
56. Flow cytometric analysis of extracellular vesicles from cell-conditioned Media10.3791/59128 ↗
57. Corneal epithelial wound healing and bactericidal effect of conditioned medium from human uterine cervical stem cells10.1167/iovs.14-15859 ↗
58. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury10.1371/journal.pone.0033115 ↗
59. Cell-cell communication: new insights and clinical implications10.1038/s41392-024-01888-z ↗
60. Understanding MAPK signaling pathways in apoptosis10.3390/ijms21072346 ↗
61. Effects of mesenchymal stem cell-derived paracrine signals and their delivery strategies10.1002/adhm.202001689 ↗
62. Hypoxic conditioned medium from Human adipose-derived stem cells promotes mouse liver regeneration through JAK/STAT3 signaling10.5966/sctm.2015-0191 ↗
63. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis10.1186/1755-1536-1-4 ↗
64. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing10.1182/blood.2019000510 ↗
65. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition10.1158/0008-5472.CAN-12-2064 ↗
66. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction10.1007/s12079-009-0077-z ↗
67. Thrombospondin 1 and its diverse roles as a regulator of extracellular matrix in fibrotic disease10.1369/0022155419851103 ↗
68. Gene expression linked to reepithelialization of Human skin wounds10.3390/ijms232415746 ↗
69. IGF-binding proteins 3 and 4 are regulators of sprouting angiogenesis10.1007/s11033-020-05339-0 ↗
70. The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration10.3390/cells10113242 ↗
71. CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis10.1371/journal.pone.0030562 ↗
72. Connective tissue growth factor (CTGF) in age-related vascular pathologies10.1007/s11357-017-9995-5 ↗
73. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting10.1038/s42003-024-05798-2 ↗
74. PI3K/AKT/mTOR pathway in angiogenesis10.3389/fnmol.2011.00051 ↗
75. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies10.1177/1947601911423031 ↗
76. The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle10.1158/1535-7163.MCT-10-0308 ↗
77. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments10.1186/s12943-023-01744-8 ↗
78. Mediated degradation of collagen via the PI3K/AKT pathway facilitates the metastasis and poor prognosis of OSCC10.3390/ijms241713312 ↗
79. VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation10.1084/jem.20160311 ↗
80. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis10.1007/s10238-021-00693-0 ↗
81. The role of integrins in inflammation and angiogenesis10.1038/s41390-020-01177-9 ↗
82. Review of integrin-targeting biomaterials in tissue engineering10.1002/adhm.202000795 ↗
83. Integrating intracellular nanovesicles into integrin trafficking pathways and beyond10.1007/s00018-022-04371-6 ↗
84. Pathways of integrins in the endo-lysosomal system10.1007/s42977-022-00120-9 ↗
85. Inhibition of αvβ3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles10.1186/s12964-020-00630-w ↗
86. Extracellular vesicles: critical players during cell migration10.1016/j.devcel.2021.03.020 ↗
87. Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential10.1080/20013078.2018.1560809 ↗
88. Formation of a protein corona on the surface of extracellular vesicles in blood plasma10.1002/jev2.12140 ↗
89. The fibronectin synergy site re-enforces cell adhesion and mediates a crosstalk between integrin classes10.7554/eLife.22264 ↗
90. Poly(l-lactic acid) scaffold releasing an α10.1021/acsabm.2c00890 ↗
91. Mitochondrial fragmentation and ROS signaling in wound response and repair10.1186/s13619-022-00141-8 ↗
92. Downregulation of miRNAs during delayed wound healing in diabetes: role of Dicer10.2119/molmed.2014.00186 ↗
93. Mechanisms of MHC-I downregulation and role in immunotherapy response10.3389/fimmu.2022.844866 ↗
94. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential10.1186/1478-811X-12-26 ↗